Form 8-K ARATANA THERAPEUTICS, For: Nov 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Aratana Therapeutics (PETX) Tops Q3 EPS by 6c
November 11, 2014 9:14 AM ESTAratana Therapeutics (NASDAQ: PETX) reported Q3 EPS of ($0.35), $0.06 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $43 thousand versus the consensus estimate of $220 thousand.
For earnings history and earnings-related data on Aratana Therapeutics (PETX) click here.
... More


